Jared Rowley, MD
Radiation Oncology · Brooklyn, NYNPI 1588197453
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.1%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Icotec Medical Inc. accounts for 75.0% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $2,779, 8.9 times the $312 reported in 2023.
Across 31 payments — averaging $109.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Icotec Medical Inc.$3K
- AstraZeneca$385
- Mevion_medical_systems_inc$171
- Novartis$69
- Blue Earth Diagnostics$67
- MIM Software Inc.$50
- plus $107 from 4 others
What the payments were for
- Speaking & faculty fees$501%
- Travel & lodging$1,87255%
- Food & beverage$1,47343%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Icotec Medical Inc. | 11 | $2,544 |
| AstraZeneca | 11 | $385 |
| Mevion_medical_systems_inc | 1 | $171 |
| Novartis | 1 | $69 |
| Blue Earth Diagnostics | 2 | $67 |
| MIM Software Inc. | 1 | $50 |
| Angiodynamics, Inc. | 1 | $37 |
| Genmab U.S., Inc. | 1 | $32 |
| Merck | 1 | $22 |
| Syndax Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vader Pedicle System$171
- PTS250$171
- IMFINZI$125
How this compares
$3,394 in reported general payments places this provider in the 80th percentile of 397 radiation oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 26 | $256 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Brooklyn
- Hani AshamallaBrooklyn$7K
- David BerlachBrooklyn$6K
- Thomas DanielsBrooklyn$4K
- Chung ChungSyracuse$3.1M
- Michael ZelefskyNew York$946K
- Jeffrey BogartSyracuse$772K
- Steven FinkelsteinSyracuse$578K
- Shawn ZimbergPlainview$411K
- Edward ObedianOyster Bay$391K
- Nancy LeeNew York$233K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.